Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.85
Bid: 0.80
Ask: 0.90
Change: 0.00 (0.00%)
Spread: 0.10 (12.50%)
Open: 0.80
High: 0.875
Low: 0.825
Prev. Close: 0.85
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Cineworld Falls On Warner Streaming Plans

Fri, 04th Dec 2020 10:33

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

BP, up 3.3%. The oil major was the best performing FTSE 100 stock after members of the OPEC+ cartel struck a deal to increase production over the coming months, but by less than anticipated in their previous accord.

----------

SSE, up 3.0%. The Perth, Scotland-based utility is selling a 10% stake in the UK Dogger Bank A and B project to Italian oil major Eni for GBP202.5 million. Eni will buy another 10% stake from Norway's Equinor to have 20% alongside SSE's 40% and Equinor's 40%.

----------

FTSE 100 - LOSERS

----------

Rolls-Royce, down 3.5%. The jet engine maker was the worst-performing blue chip stock, giving back some of this week's bumper gains. It had risen 16% on Thursday as positive vaccine developments boosted the prospects of global travel. The aerospace stock remains up 54% in the past month, though down 46% in the past year.

----------

FTSE 250 - WINNERS

----------

Micro Focus International, up 10%. The software firm was on Thursday touted by Amazon Web Services as one of the businesses that can help companies migrate data to the cloud. AWS noted Micro's deployment environment software which it provided to Kmart Australia.

----------

Premier Oil, up 6.7%. Like BP, the mid-cap oil company's shares rose following Thursday's OPEC+ meeting.

----------

FTSE 250 - LOSERS

----------

Cineworld Group, down 11%. AT&T subsidiary Warner Bros will release its entire 2021 slate of movies on HBO Max streaming and in theatres simultaneously, including "The Matrix 4" and Denis Villeneuve's "Dune" remake, the studio announced in a landmark response to the pandemic Thursday. The "hybrid model" will see films available on HBO Max streaming in the US for one month from the date of their theatrical release.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

N4 Pharma, up 52%. The Chellaston, England-based pharmaceutical company made further gains after it announced on Thursday that cancer drug Nuvec can be freeze dried and stored for 14 day without a significant drop in performance. N4 Pharma said Nuvec formulations which had been freeze dried and then stored for 14 days, either at room temperature or at four degrees celsius, showed no significant drop in in vitro transfection capability following its reconstitution.

----------

Hunters Property, up 44%. The Yorkshire-based estate agent confirmed it received a preliminary approach from Property Franchise Group over a potential takeover offer. Property Franchise shares were down 5.5%.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Petro Matad, down 8.7%. The oil firm said a meeting on the awarding of the Block XX exploitation licence in Mongolia has been postponed due to lockdown measures.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
Today 13:32

IN BRIEF: N4 Pharma loss widens but "great optimism" remains

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company focused on the development of Nuvec - Posts revenue of GBP1,953 in 2023, compared to no revenue a year ago. Pretax loss widens to GBP1.4 million from GBP1.2 million. Looks ahead to the rest of 2024 with "great optimism."

Read more
18 Apr 2024 12:14

N4 Pharma sees potential in Nuvec delivery method for cancer treatment

(Alliance News) - N4 Pharma PLC on Thursday reported that its novel delivery system for cancer treatment has shown promise, after a successful trial.

Read more
15 Feb 2024 13:17

N4 Pharma shares jump on latest Nuvec developments

(Sharecast News) - N4 Pharma announced a significant advancement in the development of Nuvec, an innovative delivery system tailored for cancer treatments, gene therapy, and vaccines, on Thursday.

Read more
15 Feb 2024 12:06

IN BRIEF: N4 Pharma shares rise on "encouraging" Nuvec research

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company, focused on the development of Nuvec - Reports an "encouraging" update from its Nuvec delivery system for cancer treatments, gene therapy and vaccines. It has completed in-vitro experiments combining epidermal growth factor receptor and polo like kinase 1 molecules onto a Nuvec nanoparticle, before testing it on lung cancer cells. "The work clearly shows that there is a strong beneficial effect at 48 hours on cellular inhibition compared to single dose siRNA, by combining both EGFR and PLK1 onto the same particle," N4 says.

Read more
15 Feb 2024 10:52

AIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A markets

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
19 Jan 2024 13:00

N4 Pharma's Nuvec granted patent in India

(Sharecast News) - N4 Pharma, a pharmaceutical company developing the cancer vaccine delivery system Nuvec, announced on Friday that it has received confirmation from the University of Queensland regarding the granting of its patent for Nuvec in India.

Read more
19 Jan 2024 09:26

IN BRIEF: N4 Pharma gets India patent for medical delivery system

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company, focused on the development of Nuvec - University of Queensland has informed the company that it has been notified by its Indian patent attorney of the granting of its patent for Nuvec in India. Nuvec is a novel silica nanoparticle delivery system for cancer treatments, gene therapy and vaccines. N4 Pharma says the granted patent in India is for a composition of matter patent for the particle itself, alongside the manufacturing process relating to how the particle is made. Says it matches the patents granted in the US, Canada, Europe, Japan, Australia and China.

Read more
16 Jan 2024 14:05

N4 Pharma subsidiary agrees work programme for glaucoma treatment

(Sharecast News) - N4 Pharma announced a significant development through its subsidiary Nanogenics on Tuesday, after Nanogenics inked a contract to initiate the formulation and sequence selection work for its ECP105 product, aimed at pre-clinical studies at King's College, London.

Read more
16 Jan 2024 13:26

IN BRIEF: N4 Pharma touts contract to test glaucoma treatment, ECP105

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company, focused on the development of Nuvec, a novel silica nanoparticle delivery system, for vaccines and therapeutics - Says subsidiary, Nanogenics Ltd, has signed a contract to start the formulation and sequence selection work to prepare its ECP105 product for testing in pre-clinical studies at King's College, London.

Read more
8 Jan 2024 12:30

N4 Pharma reports progress in Nuvec clinical research

(Sharecast News) - Pharmaceutical delivery system developer N4 Pharma reported significant progress in its research efforts to enhance viral vector performance using Nuvec on Monday.

Read more
8 Jan 2024 09:11

N4 Pharma hails increased efficacy of Nuvec when complexed with AAV8

(Alliance News) - N4 Pharma PLC on Monday said that a series of experiments have shown that Nuvec can deliver increased transduction efficacy, when complexed with Adeno-Associated virus 8.

Read more
18 Dec 2023 16:55

LONDON MARKET CLOSE: FTSE 100 outperforms European peers

(Alliance News) - Stock prices in London closed higher on Monday, after investors shrugged off hawkish comments from US Federal Reserve officials amid festive cheer.

Read more
18 Dec 2023 12:43

N4 Pharma rises on successful results from Nuvec administration

(Alliance News) - N4 Pharma PLC on Monday announced the successful oral administration of Nuvec with a DNA plasmid after receiving promising results from its research programme with the University of Queensland.

Read more
18 Dec 2023 11:17

N4 Pharma upbeat on recent Nuvec developments

(Sharecast News) - N4 Pharma updated the market on Monday on its ongoing research efforts related to Nuvec, its delivery system designed for cancer treatments and vaccines.

Read more
7 Dec 2023 18:28

TRADING UPDATES: N4 Pharma hails "encouraging" siRNA research

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.